9781573318549 - advances against aspergillosis i: clinical science: medical science, volume 1272 (13 risultati)
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Brossura
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 73,34
EUR 2,29 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Advances Against Aspergillosis Format: Paperback
Editor: Karl V. Clemons (Stanford University; Santa Clara Valley Medical Centre); Malcolm D. Richardson (University of Helsinki, Finland); David S. Perlil
- Brossura
Da: INDOO, Avenel, NJ, U.S.A.INDOO
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 75,88
Spedizione gratuitaSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Brand New.
- Brossura
Da: Phatpocket Limited, Waltham Abbey, HERTS, Regno UnitoPhatpocket Limited
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 74,72
EUR 12,45 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: Like New. Used - Like New. Book is new and unread but may have minor shelf wear. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Brossura
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 87,29
EUR 2,29 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: As New. Unread book in perfect condition.
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Brossura
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 78,00
EUR 17,55 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: As New. Unread book in perfect condition.
- Brossura
- Prima edizione
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 99,01
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challengeparticularly in the face of increasing antifungal resistance. Bringing together the worlds leaders in the Aspergillus and aspergillosis fields to promote cross-disciplin…ary collaboration among clinicians, industry, and scientific experts, the Advances Against Aspergillosis conference was held January 2628, 2012 in Istanbul, Turkey. This first of two Annals volumes contains short reviews encapsulating recent clinical findings on aspergillosis. Among the topics included are the application of diagnostic markers to invasive aspergillosis in children, risk stratification for invasive aspergillosis in immunocompromised patients, use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis, immune regulation in idiopathic bronchiectasis, and management of chronic pulmonary aspergillosis. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Brossura
- Prima edizione
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 106,09
EUR 9,50 spedizioneSpedito da Irlanda a U.S.A.Quantità: 15 disponibili
Condizione: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pa…ges: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . .
- Brossura
Da: Ubiquity Trade, Miami, FL, U.S.A.Ubiquity Trade
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 115,21
EUR 2,60 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Brand new! Please provide a physical shipping address.
Advances Against Aspergillosis I : Clinical Science
Clemons, Karl V. (EDT); Richardson, Malcolm (EDT); Perlil, David S. (EDT)
- Brossura
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 114,90
EUR 17,55 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: New.
- Brossura
Da: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 131,45
EUR 9,09 spedizioneSpedito in U.S.A.Quantità: 15 disponibili
Condizione: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Editor(s): Clemons, Karl V.; Richardson, Malcolm D.; Perlin, David S. Series: Annals of the New York Academy of Sciences. Num Pa…ges: 252 pages, Illustrations. BIC Classification: PSAF; PSG. Category: (P) Professional & Vocational. Dimension: 252 x 177 x 5. Weight in Grams: 226. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
- Brossura
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 104,32
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.KlappentextAspergillosis, the leading fungal ca.
- Brossura
Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Come nuovo
EUR 144,63
EUR 29,25 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Brossura
- Prima edizione
Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 153,31
EUR 32,04 spedizioneSpedito da Australia a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challengeparticularly in the face of increasing antifungal resistance. Bringing together the worlds leaders in the Aspergillus and aspergillosis fields to promote cross-disciplin…ary collaboration among clinicians, industry, and scientific experts, the Advances Against Aspergillosis conference was held January 2628, 2012 in Istanbul, Turkey. This first of two Annals volumes contains short reviews encapsulating recent clinical findings on aspergillosis. Among the topics included are the application of diagnostic markers to invasive aspergillosis in children, risk stratification for invasive aspergillosis in immunocompromised patients, use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis, immune regulation in idiopathic bronchiectasis, and management of chronic pulmonary aspergillosis. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
